Tardive Dyskinesia (TD) Treatment Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Published: Nov 2023

Pages: 147

SKU: IRTNTR76758

Snapshot

Tardive Dyskinesia (TD) Treatment Market Forecast 2024-2028

The tardive dyskinesia (TD) treatment market size is estimated to grow by USD 632.45 million at a CAGR of 4.73% between 2023 and 2028.

To early detection of growing cases of mental disorders, including schizophrenia, depression, and others, the tardive dyskinesia treatment is beneficial. In addition, TD is prompted by a long intake of medicines that block dopamine receptors in the brain to treat psychological disorders like schizophrenia. Furthermore, the prolonged intake of medications to treat mental illness can lead to TD, and the treatment will help patients revive.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by End-user, Product, and Geography Analysis

End-user Analysis

The market share growth by the hospital pharmacy segment will be significant during the forecast period. The regulatory systems for pharmacies favor the dominance of hospital pharmacies in the market. Hospitals are significant healthcare locations where tardive dyskinesia treatments are consulted and carried out, and patients receive medical attention, which in turn fuels the demand for hospital pharmacies.

Get a glance at the market contribution of various segments Download PDF Sample

The hospital pharmacy segment was valued at USD 1.05 billion in 2018. The growing cases of mental disorders across the world are further fueling the market. Hence, the growing cases of mental disorders and easy governance of hospital pharmacies are driving the demand for TD drugs from hospital pharmacies, which in turn will fuel the growth of the global tardive dyskinesia (TD) treatment market during the forecast period.

Product Analysis

The Austedo and Ingrezza are used to treat the movement disorder chorea, which is associated with Huntington's Disease, and to treat tardive dyskinesia. These products are being used to block vesicular monoamine transporter type 2 (VMAT2) and reduce dopamine uptake in the brain. Although some reduction in symptoms may be noticed within a week or two, it can take up to 32 weeks (for TD) to have an effect. Thus, the high prevalence of tardive dyskinesia is anticipated to fuel the growth of the Austedo and Ingrezza segments, which in turn will drive the growth of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in North America is expected to witness significant growth due to increasing healthcare expenditure and the presence of well-established healthcare infrastructure.

Furthermore, anyone who has been treated for schizophrenia, bipolar disorder, schizoaffective disorder, anxiety, or depression and has taken or is taking antipsychotics is at high risk for developing TD. Hence, the growing cases of such bipolar disorders will lead to a higher prevalence of TD, which in turn will fuel the growth of the market in North America during the forecast period.

Buy Full Report Now

Key Tardive Dyskinesia Treatment Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market growth analysis report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Abbott Laboratories: The company offers tardive dyskinesia treatment such as Aripiprazole or abilify drug.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Key Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key trends, and challenges.

Significant Trends

Initiatives to spread awareness regarding treatment of tardive dyskinesia is one of the major market trends. Many governments are promoting the awareness of TD by launching awareness week programs. All 50 states in the US, Washington, DC, and various mental health advocacy organizations have recognized the first week of May (1-7) 2023 as TD Awareness Week. This awareness week addressed approximately 600,000 Americans living with involuntary movement disorder.

Furthermore, Teva Pharmaceutical Industries Ltd. launched the It's Not OK - It's TD national television advertising campaign to raise awareness of TD and Austedo (Deutetrabenazine) tablets in May 2021. Hence, such initiatives to spread awareness regarding treatment of tardive dyskinesia are expected to drive the market growth and trends during the forecast period.

Major Challenges

Side effects related to tardive dyskinesia drugs is a challenge that affects market growth. The effective and FDA-approved drugs for the treatment of tardive dyskinesia are Austedo and Ingrezza. However, these drugs have certain side effects that can have negative impacts on human health. Agitation or restlessness, sleep problems, and swellings in the nose and throat are some of the side effects of Austedo observed in people who received the treatment for TD

Furthermore, boxed warning, long QT syndrome, neuroleptic malignant syndrome (NMS), and allergic reactions are some serious side effects that have been reported who received Austedo for the treatment of TD. Hence, the side effects related to tardive dyskinesia drugs are expected to negatively affect the growth of the market during the forecast period.

Buy Now Full Report

Key Customer Landscape

The market growth and forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

The Tardive Dyskinesia Therapeutics Market addresses involuntary movements affecting the tongue, face, trunk, and extremities, often induced by long-term usage of psychiatric medications. Innovative treatments like valbenazine (INGREZZA) and deutetrabenazine (AUSTEDO), both VMAT2 inhibitors, mitigate symptoms. Organizations like John Wiley & Sons, Inc. and the HealthWell Foundation offer financial support, aiding adults and children with prescription drugs through assistance programs for coinsurance, copayments, and deductibles. As a non-profit organization, HealthWell Foundation plays a crucial role in ensuring access to TD treatments, alleviating the financial burden on affected individuals and promoting their overall well-being.

Segment Overview

The market research and growth report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

End-User Outlook
- Hospital pharmacy
- Retail pharmacy
- Online pharmacy

Product Outlook
- Austedo and lngrezza
- Amantadine
- Others

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Argentina
  - Australia
  - Brazil

Tardive Dyskinesia Treatment Market Scope
Market Report Coverage	Details
Page number	147
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 4.73%
Market Growth 2024-2028	USD 632.45 million
Market structure	Fragmented
YoY growth 2023-2024(%)	4.22
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Germany, UK, France, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Abbott Laboratories, Actiza Pharmaceutical Pvt. Ltd., Alembic Pharmaceuticals Ltd., Aspire Pharma Ltd., Centaur Pharmaceuticals Pvt. Ltd., Cipla Ltd., Hetero Labs Ltd., Lannett Co. Inc., Luye Pharma Group Ltd., Neurocrine Biosciences Inc., Novartis AG, Psicofarma S. A. de C. V, Ryon pharma, Sawai Group Holdings Co. Ltd., Slate Run Pharmaceuticals LLC, Solco Healthcare, SOM Innovation Biotech S.A., SteriMax Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our market trends and analysis report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2024 and 2028
Precise estimation of the market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global tardive dyskinesia treatment market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global tardive dyskinesia treatment market 2018 - 2022 ($ million)

4.2 End-user Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
- Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)

6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user

6.3 Hospital pharmacy - Market size and forecast 2023-2028
- Exhibit 34: Chart on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Hospital pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Hospital pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Hospital pharmacy - Year-over-year growth 2023-2028 (%)

6.4 Retail pharmacy - Market size and forecast 2023-2028
- Exhibit 38: Chart on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Retail pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Retail pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Retail pharmacy - Year-over-year growth 2023-2028 (%)

6.5 Online pharmacy - Market size and forecast 2023-2028
- Exhibit 42: Chart on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Online pharmacy - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Online pharmacy - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Online pharmacy - Year-over-year growth 2023-2028 (%)

6.6 Market opportunity by End-user
- Exhibit 46: Market opportunity by End-user ($ million)
- Exhibit 47: Data Table on Market opportunity by End-user ($ million)

7 Market Segmentation by Product

7.1 Market segments
- Exhibit 48: Chart on Product - Market share 2023-2028 (%)
- Exhibit 49: Data Table on Product - Market share 2023-2028 (%)

7.2 Comparison by Product
- Exhibit 50: Chart on Comparison by Product
- Exhibit 51: Data Table on Comparison by Product

7.3 Austedo and Ingrezza - Market size and forecast 2023-2028
- Exhibit 52: Chart on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Austedo and Ingrezza - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Austedo and Ingrezza - Year-over-year growth 2023-2028 (%)

7.4 Amantadine and others - Market size and forecast 2023-2028
- Exhibit 56: Chart on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Amantadine and others - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Amantadine and others - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Amantadine and others - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Product
- Exhibit 60: Market opportunity by Product ($ million)
- Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.11 France - Market size and forecast 2023-2028
- Exhibit 99: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on France - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Abbott Laboratories
- Exhibit 111: Abbott Laboratories - Overview
- Exhibit 112: Abbott Laboratories - Business segments
- Exhibit 113: Abbott Laboratories - Key news
- Exhibit 114: Abbott Laboratories - Key offerings
- Exhibit 115: Abbott Laboratories - Segment focus

12.4 Alembic Pharmaceuticals Ltd.
- Exhibit 116: Alembic Pharmaceuticals Ltd. - Overview
- Exhibit 117: Alembic Pharmaceuticals Ltd. - Product / Service
- Exhibit 118: Alembic Pharmaceuticals Ltd. - Key offerings

12.5 Aspire Pharma Ltd.
- Exhibit 119: Aspire Pharma Ltd. - Overview
- Exhibit 120: Aspire Pharma Ltd. - Product / Service
- Exhibit 121: Aspire Pharma Ltd. - Key offerings

12.6 Centaur Pharmaceuticals Pvt. Ltd.
- Exhibit 122: Centaur Pharmaceuticals Pvt. Ltd. - Overview
- Exhibit 123: Centaur Pharmaceuticals Pvt. Ltd. - Product / Service
- Exhibit 124: Centaur Pharmaceuticals Pvt. Ltd. - Key offerings

12.7 Cipla Ltd.
- Exhibit 125: Cipla Ltd. - Overview
- Exhibit 126: Cipla Ltd. - Business segments
- Exhibit 127: Cipla Ltd. - Key news
- Exhibit 128: Cipla Ltd. - Key offerings
- Exhibit 129: Cipla Ltd. - Segment focus

12.8 Lannett Co. Inc.
- Exhibit 130: Lannett Co. Inc. - Overview
- Exhibit 131: Lannett Co. Inc. - Product / Service
- Exhibit 132: Lannett Co. Inc. - Key offerings

12.9 Luye Pharma Group Ltd.
- Exhibit 133: Luye Pharma Group Ltd. - Overview
- Exhibit 134: Luye Pharma Group Ltd. - Business segments
- Exhibit 135: Luye Pharma Group Ltd. - Key offerings
- Exhibit 136: Luye Pharma Group Ltd. - Segment focus

12.10 Neurocrine Biosciences Inc.
- Exhibit 137: Neurocrine Biosciences Inc. - Overview
- Exhibit 138: Neurocrine Biosciences Inc. - Product / Service
- Exhibit 139: Neurocrine Biosciences Inc. - Key offerings

12.11 Novartis AG
- Exhibit 140: Novartis AG - Overview
- Exhibit 141: Novartis AG - Business segments
- Exhibit 142: Novartis AG - Key offerings
- Exhibit 143: Novartis AG - Segment focus

12.12 Psicofarma S. A. de C. V
- Exhibit 144: Psicofarma S. A. de C. V - Overview
- Exhibit 145: Psicofarma S. A. de C. V - Product / Service
- Exhibit 146: Psicofarma S. A. de C. V - Key offerings

12.13 Sawai Group Holdings Co. Ltd.
- Exhibit 147: Sawai Group Holdings Co. Ltd. - Overview
- Exhibit 148: Sawai Group Holdings Co. Ltd. - Product / Service
- Exhibit 149: Sawai Group Holdings Co. Ltd. - Key offerings

12.14 SOM Innovation Biotech S.A.
- Exhibit 150: SOM Innovation Biotech S.A. - Overview
- Exhibit 151: SOM Innovation Biotech S.A. - Product / Service
- Exhibit 152: SOM Innovation Biotech S.A. - Key offerings

12.15 SteriMax Inc.
- Exhibit 153: SteriMax Inc. - Overview
- Exhibit 154: SteriMax Inc. - Product / Service
- Exhibit 155: SteriMax Inc. - Key offerings

12.16 Sun Pharmaceutical Industries Ltd.
- Exhibit 156: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 157: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 158: Sun Pharmaceutical Industries Ltd. - Key offerings

12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 159: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 160: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 161: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 162: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 163: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 164: Inclusions checklist
- Exhibit 165: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 166: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 167: Research methodology
- Exhibit 168: Validation techniques employed for market sizing
- Exhibit 169: Information sources

13.5 List of abbreviations
- Exhibit 170: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

tardive dyskinesia treatment market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis